Shin Jung-yong, CEO of Celltrion Canada (left), and Lee Sung-won, CEO of WellsCare (right), pose after signing a MOU to ...
The treatment group showed significant improvements in key clinical and metabolic biomarkers from the third day of therapy, suggesting that this technique may represent a promising adjunctive approach ...
Sepsis remains one of the leading causes of mortality in hospitalized patients worldwide, and innovative therapeutic ...
Dermatologists explain the science behind wildly popular treatments like red light therapy, which is now available at ...
An LED-based intraoral device for photobiomodulation therapy was safe and reduced severe oral mucositis in patients with head and neck cancers. An LED-based intraoral device for photobiomodulation ...
Is the Ammortal Chamber the future of recovery or just high-end wellness theater? Explore the claims and costs behind this ...
TECHNOLOGIES HELPED HIM TURN THINGS AROUND. YEAH, DEIRDRE. RICO PETRINI TOLD ME HE SUFFERED AT LEAST 25 CONCUSSIONS AND 15,000 REPETITIVE BRAIN IMPACTS IN HIS CAREER, SO NOW HE IS HOPING THIS UNIQUE ...
Please provide your email address to receive an email when new articles are posted on . The Valeda light delivery system received de novo marketing authorization in 2024. The acquisition is expected ...
(RTTNews) - Alcon (ALC) announced its intention to acquire LumiThera, Inc., and its PBM device for the treatment of early and intermediate dry AMD. LumiThera is an ophthalmic medical device company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback